ATE80894T1 - Reinigung des natuerlichen kolonie-stimulierenden faktors-1. - Google Patents

Reinigung des natuerlichen kolonie-stimulierenden faktors-1.

Info

Publication number
ATE80894T1
ATE80894T1 AT86901265T AT86901265T ATE80894T1 AT E80894 T1 ATE80894 T1 AT E80894T1 AT 86901265 T AT86901265 T AT 86901265T AT 86901265 T AT86901265 T AT 86901265T AT E80894 T1 ATE80894 T1 AT E80894T1
Authority
AT
Austria
Prior art keywords
purification
stimulating factor
colony stimulating
natural
natural colony
Prior art date
Application number
AT86901265T
Other languages
English (en)
Inventor
Michael P Mcgrogan
Kenneth Wilson
James E Strickler
Albert Boosman
Mary Kim Warren
Richard E Stanley
Original Assignee
Cetus Oncology Corp
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp, Einstein Coll Med filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ATE80894T1 publication Critical patent/ATE80894T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AT86901265T 1985-02-05 1986-02-05 Reinigung des natuerlichen kolonie-stimulierenden faktors-1. ATE80894T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69835885A 1985-02-05 1985-02-05
EP86901265A EP0211899B1 (de) 1985-02-05 1986-02-05 Reinigung des natürlichen kolonie-stimulierenden faktors-1
PCT/US1986/000251 WO1986004587A1 (en) 1985-02-05 1986-02-05 Purification of native colony stimulating factor-1

Publications (1)

Publication Number Publication Date
ATE80894T1 true ATE80894T1 (de) 1992-10-15

Family

ID=24804907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86901265T ATE80894T1 (de) 1985-02-05 1986-02-05 Reinigung des natuerlichen kolonie-stimulierenden faktors-1.

Country Status (6)

Country Link
EP (1) EP0211899B1 (de)
JP (2) JP2512453B2 (de)
AT (1) ATE80894T1 (de)
AU (1) AU590543B2 (de)
DE (1) DE3686794T2 (de)
WO (1) WO1986004587A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
EP0209601B1 (de) * 1985-02-05 1993-12-15 Cetus Oncology Corporation Rekombinanter koloniestimulierender faktor-1
AU590543B2 (en) * 1985-02-05 1989-11-09 Albert Einstein College Of Medicine Of Yeshiva University Purification of native colony stimulating factor-1
US6146851A (en) * 1985-02-05 2000-11-14 Chiron Corporation DNA encoding NV2 (long form) and carboxy truncated fragments thereof
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5792450A (en) * 1985-02-05 1998-08-11 Chiron Corporation Purified human CSF-1
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
ATE79761T1 (de) * 1985-11-27 1992-09-15 Genetics Inst Behandlung einer krankheit vom aids-typ.
ATE92966T1 (de) * 1986-05-06 1993-08-15 Genetics Inst Herstellung von m-csf.
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
US5650297A (en) * 1986-09-17 1997-07-22 Otsuka Pharmaceutical Co., Ltd. DNA encoding human colony-stimulating factors
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
EP0276551B1 (de) * 1986-12-07 1992-03-18 Morinaga Milk Industry Co., Ltd. Kolonie-stimulierender Faktor und Verfahren zu seiner Herstellung
AU8313187A (en) * 1986-12-31 1988-07-07 Cetus Corporation Pharmaceutical composition of colony stimulating factor-i and granulocyte colony stimulating factor
DE3853721T2 (de) * 1987-09-22 1995-10-19 Cetus Oncology Corp Verwendungen von rekombinantem koloniestimulierendem faktor-1.
JPH0611705B2 (ja) * 1988-02-10 1994-02-16 新技術事業団 血小板減少症治療剤
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
US5888495A (en) * 1988-05-23 1999-03-30 Genetics Institute, Inc. Method of producing storage stable M-CSF lyophilizates
US5171675A (en) * 1988-07-28 1992-12-15 Cerretti Douglas P Macrophage colony stimulating factor-γ
JPH02225418A (ja) * 1989-02-28 1990-09-07 Morinaga Milk Ind Co Ltd 抗悪性腫瘍剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
JPS59137417A (ja) * 1983-01-28 1984-08-07 Morinaga Milk Ind Co Ltd 人尿由来コロニ−形成刺激因子及びカリクレインの製造法
US4504586A (en) * 1983-02-03 1985-03-12 Amgen Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1
ATE67244T1 (de) * 1984-07-06 1991-09-15 Sandoz Ag Herstellung und reinigung von lymphokinen.
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
AU590543B2 (en) * 1985-02-05 1989-11-09 Albert Einstein College Of Medicine Of Yeshiva University Purification of native colony stimulating factor-1

Also Published As

Publication number Publication date
DE3686794D1 (de) 1992-10-29
JPS63502271A (ja) 1988-09-01
EP0211899B1 (de) 1992-09-23
JPH09136899A (ja) 1997-05-27
AU590543B2 (en) 1989-11-09
EP0211899A1 (de) 1987-03-04
JP2512453B2 (ja) 1996-07-03
DE3686794T2 (de) 1993-03-04
WO1986004587A1 (en) 1986-08-14
AU5454486A (en) 1986-08-26

Similar Documents

Publication Publication Date Title
ATE80894T1 (de) Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
DE69231469T2 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
ES2165830T1 (es) Kit para radiomarcar proteinas con itrio-90.
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
YU46001B (sh) Postupak za dobijanje novih peptida
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
KR870700638A (ko) 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도
EP0220241A4 (de) Gereinigtes protein mit angiogenischer wirkung und dessen herstellung.
ATE81290T1 (de) Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
FI864830A0 (fi) Ihon lävistävä neula luuosien kiinnittämiseksi
PT84849A (pt) Enhanced expression of human interleukin-2 in mammalian cells
DK495486D0 (da) Proteiner med human-gamma-interferon-aminosyredelsekvenser, deres fremstilling og anvendelse
NO873427L (no) Hudpleiepreparater med keratolytisk og antiinflammatorisk virkning.
DE3666826D1 (en) Human natural inhibitor of collagenases
IT8647912A0 (it) Procedimento enzimatico per preparare l'amminoacidi contenenti zolfo
NZ215851A (en) Permanent hair waving composition containing pantethine or pantetheine
IT8520977A0 (it) Uso della gelatina per favorire ed aumentare la crescita dei capelli
NZ235774A (en) Peptide with amino acid sequence homologous to portion of porcine somatotropin; antibodies and their use in potentiating the activity of pst
DK369886A (da) Hidtil ukendte acylphosphotriamider og pharmaceutisk komposition indeholdende samme til aendring af lipidindholdet i blodplasma hospattedyr
KR900019561A (ko) 인체 과립성 백혈구의 콜로니 자극인자
IT8619306A1 (it) Procedimento e composizione per combattere la tignola crociata della vite
GB2176719B (en) Improvements in and relating to cleaning of gases
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee